Lv41
440 积分 2024-01-30 加入
Splenic PD-L1 + Myeloid-Derived Suppressor Cells Induce Contact-Dependent Alveolar Macrophage Dysfunction in Early Sepsis
1小时前
已关闭
LBA13 Nivolumab and ipilimumab in early-stage triple negative breast cancer (TNBC) with tumor-infiltrating lymphocytes (TILs): First results from the BELLINI trial
20天前
已关闭
Towards targeting the breast cancer immune microenvironment
3个月前
已完结
Role of the Tumor Microenvironment in Mediating Resistance to Anti-HER2 Antibodies
3个月前
已完结
The puppet master in the breast cancer “microecological community”: spatial and metabolic regulation of macrophage heterogeneity
3个月前
已完结
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial
3个月前
已完结
The prognostic and predictive values of differential expression of exosomal receptor tyrosine kinases and associated with the PI3K/AKT/mTOR signaling in breast cancer patients undergoing neoadjuvant chemotherapy
6个月前
已完结
Immune checkpoint inhibition in early-stage triple-negative breast cancer
6个月前
已完结
Stromal grading predicts pathologic complete response and prognosis in triple-negative breast cancer
6个月前
已完结
The anti-cancer immune response in breast cancer: current and emerging biomarkers and treatments
6个月前
已完结
皖公网安备34019202002308
